Anupam Rasayan India Second Quarter 2025 Earnings: EPS: ₹1.51 (vs ₹3.78 in 2Q 2024)
Anupam Rasayan India (NSE:ANURAS) Second Quarter 2025 Results
Key Financial Results
- Revenue: ₹2.96b (down 25% from 2Q 2024).
- Net income: ₹166.7m (down 59% from 2Q 2024).
- Profit margin: 5.6% (down from 10% in 2Q 2024). The decrease in margin was driven by lower revenue.
- EPS: ₹1.51 (down from ₹3.78 in 2Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Anupam Rasayan India Earnings Insights
Looking ahead, revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India.
Performance of the Indian Chemicals industry.
The company's share price is broadly unchanged from a week ago.
Risk Analysis
Be aware that Anupam Rasayan India is showing 4 warning signs in our investment analysis and 2 of those are concerning...
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NSEI:ANURAS
Anupam Rasayan India
Engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally.
High growth potential slight.
